Trigemina Overview
- Year Founded
-
2006
- Status
-
Out of Business
- Employees
-
12
- Latest Deal Type
-
Out of Business
Trigemina General Information
Description
Developer of non-narcotic analgesic drug products intended to develop novel, non-opioid, non-sedating, cognition neutral neurological therapies. The company's drugs are made up of novel naso-cerebral formulations for pain therapy that are delivered to through the nasal-cerebral pathway, enabling people to get relief from chronic migraine and other neuropathic pain.
Contact Information
Website
www.trigemina.comCorporate Office
- 1036 Country Club Drive
- Suite 200
- Moraga, CA 94556
- United States
Corporate Office
- 1036 Country Club Drive
- Suite 200
- Moraga, CA 94556
- United States
Trigemina Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Out of Business | 05-Aug-2020 | Completed | Out of Business | |||
| 7. Later Stage VC (Series A1) | 14-Apr-2014 | Completed | Generating Revenue | |||
| 6. Grant | 17-Jun-2013 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 12-Apr-2012 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 17-Nov-2010 | Completed | Startup | |||
| 3. Early Stage VC | 22-Dec-2009 | Completed | Startup | |||
| 2. Grant | 01-Jan-2009 | $444K | $2.41M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 09-May-2007 | $2.41M | $2.41M | Completed | Startup |
Trigemina Comparisons
Industry
Financing
Details
Trigemina Competitors (15)
One of Trigemina’s 15 competitors is Centrexion Therapeutics, a Venture Capital-Backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Centrexion Therapeutics | Venture Capital-Backed | Boston, MA | ||||
| Azevan Pharmaceuticals | Venture Capital-Backed | Bethlehem, PA | ||||
| Xalud Therapeutics | Venture Capital-Backed | New York, NY | ||||
| Rein Therapeutics | Formerly VC-backed | Austin, TX | ||||
| Phoenix PharmaLabs | Venture Capital-Backed | Salt Lake City, UT |
Trigemina Patents
Trigemina Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2024038482-A | Labeled oxytocin and method of manufacture and use | Inactive | 01-Mar-2018 | ||
| WO-2019169342-A1 | Labeled oxytocin and method of manufacture and use | Inactive | 01-Mar-2018 | ||
| JP-2025015576-A | Magnesium-containing oxytocin formulations and methods of use | Pending | 12-Apr-2016 | ||
| WO-2017180781-A1 | Magnesium-containing oxytocin formulations and methods of use | Inactive | 12-Apr-2016 | ||
| JP-2022079671-A | Magnesium-containing oxytocin preparation and method of use | Inactive | 12-Apr-2016 | A61K38/095 |
Trigemina Signals
Trigemina FAQs
-
When was Trigemina founded?
Trigemina was founded in 2006.
-
Where is Trigemina headquartered?
Trigemina is headquartered in Moraga, CA.
-
What is the size of Trigemina?
Trigemina has 12 total employees.
-
What industry is Trigemina in?
Trigemina’s primary industry is Drug Discovery.
-
Is Trigemina a private or public company?
Trigemina is a Private company.
-
What is Trigemina’s current revenue?
The current revenue for Trigemina is .
-
How much funding has Trigemina raised over time?
Trigemina has raised $7.61M.
-
Who are Trigemina’s competitors?
Centrexion Therapeutics, Azevan Pharmaceuticals, Xalud Therapeutics, Rein Therapeutics, and Phoenix PharmaLabs are some of the 15 competitors of Trigemina.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process